Evotec’s €23 Million Acquisition of Rigenerand

Freshfields Bruckhaus Deringer advised Evotec SE. DLA Piper has advised Xyence Capital SGR, Rigenand’s majority shareholder. Watson Farley & Williams supported the dissemination of minority shareholders. Lawyer Morselli supported the shareholder Medi S.r.l.

Evotec SE has announced the signing of a binding agreement under which Evotec will acquire 100% of the shares in Rigenerand Srl, a leading cell technology company, for €23m.

Founded in 2009 as a spin-off from the University of Modena and Reggio Emilia, Rigenerand is an innovator in the field of cGMP manufacturing of cell therapies. With the acquisition, Evotec gains an excellent team of experts for cGMP manufacturing of cell therapies.

The German-Italian Freshfields team included partners: Prof. Dr. Christoph H. Seibt (image – Hamburg; lead), Enrico Bazzano, Francesco Lombardo (all Corporate/M&A), Ermelinda Spinelli (antitrust and foreign trade law; all Milan); Counsel: Nicola Franceschina (real estate law; Milan); Senior/Principal Associates: Dr. Jil Rollmann (Hamburg), Valentina Gagliani, Andrea Giaretta (both Milan; all Corporate/M&A), Teresa Ammirabile (real estate law; Milan); Associates: Emanuele Cossa (real estate law), Mila Filomena Crispino (antitrust and foreign trade law; both Milan).

Internally, Evotec SE is legally managed by General Counsel Dr. advise Christian Dargel.

The DLA Piper team included Eleonora Laurito, Filippo Cecchetti, Agostino Papa, Gregorio Calabresi, Giulia Minetti Floccari and Gianmarco Sciapli.

The WFW team included Carlo Cosmelli and Roberta Sturiale.

Involved fees earner: Gregorio Calabresi – DLA Piper; Filippo Cecchetti – DLA Piper; Eleonora Laurito – DLA Piper; Giulia Minetti Floccari – DLA Piper; Agostino Papa – DLA Piper; Gianmarco Scialpi – DLA Piper; Teresa Ammirabile – Freshfields Bruckhaus Deringer LLP; Enrico Bazzano – Freshfields Bruckhaus Deringer LLP; Marco Colombo – Freshfields Bruckhaus Deringer LLP; Emanuele Cossa – Freshfields Bruckhaus Deringer LLP; Mila Filomena Crispino – Freshfields Bruckhaus Deringer LLP; Nicola Franceschina – Freshfields Bruckhaus Deringer LLP; Valentina Gagliani – Freshfields Bruckhaus Deringer LLP; Andrea Giaretta – Freshfields Bruckhaus Deringer LLP; Ludovico Goglino – Freshfields Bruckhaus Deringer LLP; Francesco Lombardo – Freshfields Bruckhaus Deringer LLP; Jil Rollmann – Freshfields Bruckhaus Deringer LLP; Christoph Seibt – Freshfields Bruckhaus Deringer LLP; Ermelinda Spinelli – Freshfields Bruckhaus Deringer LLP; Carlo Cosmelli – Watson Farley & Williams; Roberta Sturiale – Watson Farley & Williams;

Law Firms: DLA Piper; Freshfields Bruckhaus Deringer LLP; Watson Farley & Williams;

Clients: Evotec AG; Rigenerand S.r.l.; Xyence Capital SGR S.p.A. ;

Federica Tiefenthaler

Author: Federica Tiefenthaler